L V Beex
Overview
Explore the profile of L V Beex including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Westenberg A, Rutgers E, Peterse J, Hendriks J, Beex L, van Tienhoven G
Ned Tijdschr Geneeskd
. 2003 Nov;
147(44):2157-61.
PMID: 14626831
Ductal carcinoma in situ (DCIS) of the breast is diagnosed more and more often in the Netherlands as a result of mammographic population screening and improved mammography techniques. Mastectomy and...
2.
Hoogerbrugge N, Bult P, de Widt-Levert L, Beex L, Kiemeney L, Ligtenberg M, et al.
J Clin Oncol
. 2002 Dec;
21(1):41-5.
PMID: 12506168
Purpose: Women with a hereditary predisposition for breast cancer have an extremely high risk of developing invasive breast carcinoma, and many women consider prophylactic mastectomy to avoid this risk. The...
3.
Tjan-Heijnen V, Buit P, Ruers T, Beex L
Breast Cancer Res Treat
. 2002 Jan;
70(2):81-8.
PMID: 11768607
Background: Sentinel lymph node (SN) biopsy will increasingly replace axillary lymph node dissection (ALND) for staging in breast cancer. For daily practice, examination of the SN by serial sectioning (SS)...
4.
Dorssers L, van der Flier S, Brinkman A, van Agthoven T, Veldscholte J, Berns E, et al.
Drugs
. 2001 Nov;
61(12):1721-33.
PMID: 11693462
Tamoxifen has been used for the systemic treatment of patients with breast cancer for nearly three decades. Treatment success is primarily dependent on the presence of the estrogen receptor (ER)...
5.
Broeders M, Peer P, Straatman H, Beex L, Hendriks J, Holland R, et al.
Int J Cancer
. 2001 Apr;
92(2):303-8.
PMID: 11291061
Age-standardised breast cancer mortality rates have been stable for decades. However, rates have started to decline in several Western countries. In countries where population-based screening programmes for breast cancer were...
6.
Bontenbal M, Nortier J, Beex L, Bakker P, Hupperets P, Nooij M, et al.
Ned Tijdschr Geneeskd
. 2000 Jun;
144(21):984-9.
PMID: 10858788
There is an abundance of evidence that adjuvant systemic therapy with chemotherapy or endocrine therapy results in better survival for all patients with resectable breast cancer. The absolute 10-year survival...
7.
Klijn J, Beex L, Mauriac L, van Zijl J, Veyret C, Wildiers J, et al.
J Natl Cancer Inst
. 2000 Jun;
92(11):903-11.
PMID: 10841825
Background: Surgical or medical castration and antiestrogenic treatment with tamoxifen are common endocrine treatments for premenopausal women with breast cancer. However, tamoxifen therapy induces high levels of plasma estradiol, with...
8.
Pecorelli S, Wagenaar H, Vergote I, Curran D, Beex L, Wiltshaw E, et al.
Eur J Cancer
. 2000 Feb;
35(9):1331-7.
PMID: 10658523
The aim of this study was to investigate the clinical activity and toxicity of a modified PVB regimen (cisplatin, vinblastine and bleomycin) in patients with advanced or recurrent, pure granulosa...
9.
Ottevanger P, Verhagen C, Beex L
Eur J Cancer
. 1999 Aug;
35(3):386-91.
PMID: 10448287
The quality of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and the compliance with guidelines for this treatment were studied in 323 premenopausal patients with node positive breast cancer,...
10.
Beex L, Tjan-Heijnen V, Ottevanger P
Ned Tijdschr Geneeskd
. 1999 Mar;
143(1):59-60.
PMID: 10086103
No abstract available.